3,3-Dimethyl-1-Butanol and its Metabolite 3,3-Dimethylbutyrate Ameliorate Collagen-induced Arthritis Independent of Choline Trimethylamine Lyase Activity-Reference-Cited by-同舟云学术

3,3-Dimethyl-1-Butanol and its Metabolite 3,3-Dimethylbutyrate Ameliorate Collagen-induced Arthritis Independent of Choline Trimethylamine Lyase Activity

Published:2024-08-17 Issue: Volume: Page:
ISSN:0360-3997
Container-title:Inflammation
language:en
Short-container-title:Inflammation

Author:

Fechtner Sabrina,Allen Brendan E.,Chriswell Meagan E.,Jubair Widian K.,Robertson Charles E.,Kofonow Jennifer N.,Frank Daniel N.,Holers V. Michael,Kuhn Kristine A.

Funder

National Heart, Lung, and Blood Institute

National Institute of Allergy and Infectious Diseases

State of Colorado

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10753-024-02126-y.pdf

Reference101 articles.

1. Almutairi, K., et al. 2021. The global prevalence of rheumatoid arthritis: A meta-analysis based on a systematic review. Rheumatology International 41 (5): 863–877.

2. Aletaha, D., and J. S. Smolen. 2018. Diagnosis and management of rheumatoid arthritis. JAMA 320 (13): 1360.

3. Sergeant, J. C., et al. 2018. Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: Results from the UK Rheumatoid Arthritis Medication Study (RAMS). Arthritis Research & Therapy 20 (1): 147.

4. Nam, J. L., et al. 2017. Efficacy of biological disease-modifying antirheumatic drugs: A systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the Rheumatic Diseases 76 (6): 1113–1136.

5. Strand, V., et al. 2017. Discontinuation of biologic therapy in rheumatoid arthritis: Analysis from the Corrona RA registry. Rheumatol Ther 4 (2): 489–502.